Related Experiment Video
Updated: Dec 9, 2025

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
Structural and spectral analysis of anticancer active cyclo(Ala-His) dipeptide
Sefa Celik1, Gozde Yilmaz2, Aysen E Ozel1
1Physics Department, Science Faculty, Istanbul University, Istanbul, Turkey.
Cyclo(Ala-His), a cyclic dipeptide with anticancer activity, is most stable in a boat conformation. Computational and experimental analyses confirm its potential as a leading drug discovery molecule.
Area of Science:
- Computational Chemistry
- Medicinal Chemistry
- Molecular Spectroscopy
Background:
- Cyclic dipeptides exhibit significant biological activities, including anticancer properties.
- Understanding the structural and electronic properties of cyclo(Ala-His) is crucial for its therapeutic development.
Purpose of the Study:
- To determine the most stable conformation of cyclo(Ala-His) using computational methods.
- To investigate the structural and spectral properties of cyclo(Ala-His) and its dimeric forms.
- To evaluate the potential of cyclo(Ala-His) as a drug candidate through molecular docking and ADMET analysis.
Main Methods:
- Conformational analysis and Density Functional Theory (DFT) calculations.
- DFT methods (B3LYP, wb97xd) with 6-311++G(d,p) basis set for structural and spectral simulations.
- Solid-phase Fourier-transform infrared (FTIR) and Raman spectroscopy.
- In silico molecular docking with DNA.
- Drug likeness and ADMET property analysis.
Main Results:
- The boat conformation of cyclo(Ala-His) is more stable than the planar form.
- Three energetically favorable dimeric structures of cyclo(Ala-His) were identified.
- Experimental vibrational spectra (FTIR, Raman) are in good agreement with DFT-simulated spectra.
- Molecular docking suggests interaction with DNA, and ADMET analysis indicates favorable pharmacokinetic profiles.
Conclusions:
- Cyclo(Ala-His) exhibits a stable boat conformation and predictable spectral properties.
- The compound demonstrates potential for drug discovery due to favorable drug likeness and ADMET profiles.
- Further investigation into cyclo(Ala-His) as an anticancer agent is warranted.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020